Pfizer (PFE), and Sanofi (SNY) drew increased attention on Tuesday as traders reacted to the U.S. government’s move to halt ...

This was one in a continuing line of moves that have put Kennedy's vaccine skepticism into public policy, though scientists ...

Pfizer delivered a strong Q2 earnings beat, raising FY2025 guidance and demonstrating effective cost-cutting. Learn why PFE ...

A research project at Emory University is among the 22 grants and contracts that are being cancelled as the U.S. Department ...

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...

Health Secretary Robert F. Kennedy Jr.’s decision this week to cancel hundreds of millions of dollars in mRNA vaccine funding ...

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...

CAMBRIDGE, MA / ACCESS Newswire / August 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal ...

The Pfizer vaccine is the first to receive FDA approval, while the Moderna and Johnson & Johnson vaccines are available under an emergency use authorization. For children ages 12 to 15, Pfizer's ...

Pfizer, BioNTech and Moderna are experiencing a post-vaccine hangover on Wall Street this year. All three stocks surged spectacularly in 2021, thanks largely to their Covid-19 vaccines’ success ...

What's happening Updated COVID boosters from Pfizer and Moderna are available to everyone 6 months and older. Some adults can get Novavax for a booster instead. Why it matters As the virus mutates ...

Pfizer(PFE -0.46%) and Moderna (MRNA -1.74%) have been in agreement on a lot since the beginning of the pandemic. They both recognized the importance of eventually launching combined vaccines ...